MaxCyte Signs Strategic Platform License with Lyell Immunopharma
Go back to MaxCyte Signs Strategic Platform License with Lyell Immunopharma| (NASDAQ: MXCT) | Delayed: 1.05 +0.04 (3.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.01 | 52 Week High | $ | |||
| Open | $1.00 | 52 Week Low | $ | |||
| Day High | $1.06 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $ | |||
| Volume | 310,296 | |||||
| (NASDAQ: MXCT) | Delayed: 1.05 +0.04 (3.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.01 | 52 Week High | $ | |||
| Open | $1.00 | 52 Week Low | $ | |||
| Day High | $1.06 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $ | |||
| Volume | 310,296 | |||||

